Journal of Biochemistry and Physiology

Reach Us +12097300872
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Can Renalase Enzyme Control the Fate of Parkinson’s and Schizophrenia?

Dopamine is a catecholamine that is involved in the etiopathology of neurodegenerative diseases like Parkinson’s and schizophrenia. Parkinson’s disease develops as a result of dopamine deficiency in the glial beds of the brain. Schizophrenia, on the other hand, is characterized by excessive dopamine. The limited number of drugs used in Parkinson’s disease either makes up the dopamine deficiency (L-Dopa), or exercise dopamine-like effects, or prevent the breakdown of dopamine in the brain.

Special Features

Full Text

View

Track Your Manuscript

Share This Page

Media Partners

Associations